Abstract
Endocarditis caused by Candida dubliniensis is a rare event and limited to few case reports. In this report, the authors present a patient with a history of intravenous drug use and hepatitis C and endocarditis involving a prosthetic aortic valve. Also reviewed are the treatment guidelines for Candida sp. endocarditis.
MeSH terms
-
Amphotericin B / therapeutic use
-
Antifungal Agents / therapeutic use
-
Candida*
-
Candidiasis / complications*
-
Candidiasis / drug therapy
-
Candidiasis / microbiology
-
Echinocandins / therapeutic use
-
Endocarditis / drug therapy
-
Endocarditis / microbiology*
-
Fluconazole / therapeutic use
-
Humans
-
Lipopeptides / therapeutic use
-
Male
-
Micafungin
-
Middle Aged
Substances
-
Antifungal Agents
-
Echinocandins
-
Lipopeptides
-
liposomal amphotericin B
-
Amphotericin B
-
Fluconazole
-
Micafungin